This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J.-L.
Right arrow Articles by Kung, H.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J.-L.
Right arrow Articles by Kung, H.-J.

 Previous Article  |  Next Article 

J. Virol., Jan 1998, 388-395, Vol 72, No. 1
Copyright © 1998, American Society for Microbiology

Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis

JL Liu, Y Ye, LF Lee and HJ Kung
Department of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106-4960, USA.

Marek's disease virus (MDV) induces the rapid development of overwhelming T-cell lymphomas in chickens. One of its candidate oncogenes, meq (MDV Eco Q) which encodes a bZIP protein, has been biochemically characterized as a transcription factor. Interestingly, MEQ proteins are expressed not only in the nucleoplasm but also in the coiled bodies and the nucleolus. Its novel subcellular localization suggests that MEQ may be involved in other functions beyond its transcriptional potential. In this report we show that MEQ proteins are expressed ubiquitously and abundantly in MDV tumor cell lines. Overexpression of MEQ results in transformation of a rodent fibroblast cell line, Rat-2. The criteria of transformation are based on morphological transfiguration, anchorage-independent growth, and serum- independent growth. Furthermore, MEQ is able to distend the transforming capacity of MEQ-transformed Rat-2 cells through inhibition of apoptosis. Specifically, MEQ can efficiently protect Rat-2 cells from cell death induced by multiple modes including tumor necrosis factor alpha, C2-ceramide, UV irradiation, and serum deprivation. Its antiapoptotic function requires new protein synthesis, as treatment with a protein synthesis inhibitor, cycloheximide, partially reversed MEQ's antiapoptotic effect. Coincidentally, transcriptional induction of bcl-2 and suppression of bax are also observed in MEQ-transformed Rat-2 cells. Taken together, our results suggest that MEQ antagonizes apoptosis through regulation of its downstream target genes involved in apoptotic and/or antiapoptotic pathways.


This article has been cited by other articles:

  • Suchodolski, P. F., Izumiya, Y., Lupiani, B., Ajithdoss, D. K., Gilad, O., Lee, L. F., Kung, H.-J., Reddy, S. M. (2009). Homodimerization of Marek's Disease Virus-Encoded Meq Protein Is Not Sufficient for Transformation of Lymphocytes in Chickens. J. Virol. 83: 859-869 [Abstract] [Full Text]  
  • Morgan, R., Anderson, A., Bernberg, E., Kamboj, S., Huang, E., Lagasse, G., Isaacs, G., Parcells, M., Meyers, B. C., Green, P. J., Burnside, J. (2008). Sequence Conservation and Differential Expression of Marek's Disease Virus MicroRNAs. J. Virol. 82: 12213-12220 [Abstract] [Full Text]  
  • Jarosinski, K. W., Margulis, N. G., Kamil, J. P., Spatz, S. J., Nair, V. K., Osterrieder, N. (2007). Horizontal Transmission of Marek's Disease Virus Requires US2, the UL13 Protein Kinase, and gC. J. Virol. 81: 10575-10587 [Abstract] [Full Text]  
  • Murata, S., Chang, K.-S., Lee, S.-I., Konnai, S., Onuma, M., Ohashi, K. (2007). Development of a nested polymerase chain reaction method to detect oncogenic Marek's disease virus from feather tips. jvdi 19: 471-478 [Abstract] [Full Text]  
  • Okada, T., Takagi, M., Murata, S., Onuma, M., Ohashi, K. (2007). Identification and characterization of a novel spliced form of the meq transcript in lymphoblastoid cell lines derived from Marek's disease tumours. J. Gen. Virol. 88: 2111-2120 [Abstract] [Full Text]  
  • Burnside, J., Bernberg, E., Anderson, A., Lu, C., Meyers, B. C., Green, P. J., Jain, N., Isaacs, G., Morgan, R. W. (2006). Marek's Disease Virus Encodes MicroRNAs That Map to meq and the Latency-Associated Transcript.. J. Virol. 80: 8778-8786 [Abstract] [Full Text]  
  • Trapp, S., Parcells, M. S., Kamil, J. P., Schumacher, D., Tischer, B. K., Kumar, P. M., Nair, V. K., Osterrieder, N. (2006). A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis. JEM 203: 1307-1317 [Abstract] [Full Text]  
  • Murata, K., Hayashibara, T., Sugahara, K., Uemura, A., Yamaguchi, T., Harasawa, H., Hasegawa, H., Tsuruda, K., Okazaki, T., Koji, T., Miyanishi, T., Yamada, Y., Kamihira, S. (2006). A Novel Alternative Splicing Isoform of Human T-Cell Leukemia Virus Type 1 bZIP Factor (HBZ-SI) Targets Distinct Subnuclear Localization. J. Virol. 80: 2495-2505 [Abstract] [Full Text]  
  • Anobile, J. M., Arumugaswami, V., Downs, D., Czymmek, K., Parcells, M., Schmidt, C. J. (2006). Nuclear Localization and Dynamic Properties of the Marek's Disease Virus Oncogene Products Meq and Meq/vIL8. J. Virol. 80: 1160-1166 [Abstract] [Full Text]  
  • Levy, A. M., Gilad, O., Xia, L., Izumiya, Y., Choi, J., Tsalenko, A., Yakhini, Z., Witter, R., Lee, L., Cardona, C. J., Kung, H.-J. (2005). Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: A converging transforming pathway for avian oncoviruses. Proc. Natl. Acad. Sci. USA 102: 14831-14836 [Abstract] [Full Text]  
  • Jarosinski, K. W., Osterrieder, N., Nair, V. K., Schat, K. A. (2005). Attenuation of Marek's Disease Virus by Deletion of Open Reading Frame RLORF4 but Not RLORF5a. J. Virol. 79: 11647-11659 [Abstract] [Full Text]  
  • Liu, J.-L., Sheng, X., Hortobagyi, Z. K., Mao, Z., Gallick, G. E., Yung, W. K. A. (2005). Nuclear PTEN-Mediated Growth Suppression Is Independent of Akt Down-Regulation. Mol. Cell. Biol. 25: 6211-6224 [Abstract] [Full Text]  
  • Lupiani, B., Lee, L. F., Cui, X., Gimeno, I., Anderson, A., Morgan, R. W., Silva, R. F., Witter, R. L., Kung, H.-J., Reddy, S. M. (2004). Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc. Natl. Acad. Sci. USA 101: 11815-11820 [Abstract] [Full Text]  
  • Levy, A. M., Izumiya, Y., Brunovskis, P., Xia, L., Parcells, M. S., Reddy, S. M., Lee, L., Chen, H.-W., Kung, H.-J. (2003). Characterization of the Chromosomal Binding Sites and Dimerization Partners of the Viral Oncoprotein Meq in Marek's Disease Virus-Transformed T Cells. J. Virol. 77: 12841-12851 [Abstract] [Full Text]  
  • Gaudray, G., Gachon, F., Basbous, J., Biard-Piechaczyk, M., Devaux, C., Mesnard, J.-M. (2002). The Complementary Strand of the Human T-Cell Leukemia Virus Type 1 RNA Genome Encodes a bZIP Transcription Factor That Down-Regulates Viral Transcription. J. Virol. 76: 12813-12822 [Abstract] [Full Text]  
  • Le Rouzic, E, Thoraval, P, Afanassieff, M, Cherel, Y, Dambrine, G, Perbal, B (2002). Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line. Mol. Pathol. 55: 262-272 [Abstract] [Full Text]  
  • Hay, S., Kannourakis, G. (2002). A time to kill: viral manipulation of the cell death program. J. Gen. Virol. 83: 1547-1564 [Abstract] [Full Text]  
  • Kingham, B. F., Zelnik, V., Kopácek, J., Majerciak, V., Ney, E., Schmidt, C. J. (2001). The genome of herpesvirus of turkeys: comparative analysis with Marek's disease viruses. J. Gen. Virol. 82: 1123-1135 [Abstract] [Full Text]  
  • Endoh, D., Cho, K.-O., Tsukamoto, K., Morimura, T., Kon, Y., Hayashi, M. (2000). Application of Representational Difference Analysis to Genomic Fragments of Marek's Disease Virus. J. Clin. Microbiol. 38: 4310-4314 [Abstract] [Full Text]  
  • Yamaguchi, T., Kaplan, S. L., Wakenell, P., Schat, K. A. (2000). Transactivation of Latent Marek's Disease Herpesvirus Genes in QT35, a Quail Fibroblast Cell Line, by Herpesvirus of Turkeys. J. Virol. 74: 10176-10186 [Abstract] [Full Text]  
  • Tulman, E. R., Afonso, C. L., Lu, Z., Zsak, L., Rock, D. L., Kutish, G. F. (2000). The Genome of a Very Virulent Marek's Disease Virus. J. Virol. 74: 7980-7988 [Abstract] [Full Text]  
  • Lee, L. F., Wu, P., Sui, D., Ren, D., Kamil, J., Kung, H. J., Witter, R. L. (2000). The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc. Natl. Acad. Sci. USA 97: 6091-6096 [Abstract] [Full Text]  
  • Liu, J.-L., Ye, Y., Qian, Z., Qian, Y., Templeton, D. J., Lee, L. F., Kung, H.-J. (1999). Functional Interactions between Herpesvirus Oncoprotein MEQ and Cell Cycle Regulator CDK2. J. Virol. 73: 4208-4219 [Abstract] [Full Text]  
  • Parcells, M. S., Dienglewicz, R. L., Anderson, A. S., Morgan, R. W. (1999). Recombinant Marek's Disease Virus (MDV)-Derived Lymphoblastoid Cell Lines: Regulation of a Marker Gene within the Context of the MDV Genome. J. Virol. 73: 1362-1373 [Abstract] [Full Text]